Published in Am J Physiol on March 01, 1969
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J (1973) 1.08
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism. Mol Cell Biol (2016) 0.80
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65
Editorial: Measurement of delayed skin-test responses. N Engl J Med (1975) 2.99
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49
Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. J Lab Clin Med (1973) 1.75
Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med (1970) 1.56
Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes (1969) 1.34
Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology (1992) 1.22
In vitro lymphocyte response to autologous cultured lymphoid cells. Proc Soc Exp Biol Med (1971) 1.20
Complications of BCG vaccination in neoplastic disease. Ann Intern Med (1975) 1.16
Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines. Cancer Res (1972) 1.15
A simplified technique for in vitro studies of lymphocyte reactivity. Proc Soc Exp Biol Med (1972) 1.12
"Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes. Am J Med (1972) 1.11
Immunotherapy in well-controlled chronic myelocytic leukemia. N Y State J Med (1973) 1.10
Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man. N Engl J Med (1981) 1.10
Salmonellosis in disseminated malignant diseases. A seven-- year review (1959-1965). N Engl J Med (1967) 1.05
Glucagon--an essential hormone. Am J Med (1966) 1.05
STUDIES OF GLYCOGEN METABOLISM IN LIVER GLYCOGEN DISEASE (VON GIERKE'S DISEASE): SIX CASES WITH SIMILAR METABOLIC ABNORMALITIES AND RESPONSES TO GLUCAGON. J Clin Invest (1961) 1.05
Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem (1999) 1.04
Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology (1966) 1.01
Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann Intern Med (1970) 1.01
Delay in progression of malignant lymphoma after BCG vaccination. N Engl J Med (1974) 0.97
Second neoplasms with chronic lymphocytic leukemia. N Y State J Med (1976) 0.97
Incorporation of D-galactose into liver microsomal protein in vitro. Biochem Biophys Res Commun (1966) 0.96
Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol Suppl (Copenh) (1971) 0.95
Synthesis and secretion of alpha 2-(acute phase) globulin by the isolated perfused liver from injured adult rats. Biochemistry (1970) 0.93
Pyrogen in the urine of febrile patients with Hodgkin's disease. Nature (1967) 0.93
Hepatic synthesis of alpha 2 (acute phase)-globulin of rat plasma. Science (1966) 0.92
Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease. Int J Cancer (1973) 0.91
Basal plasma glucagon levels of man. J Clin Invest (1967) 0.90
Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. Endocrinology (1970) 0.90
Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes. Int J Cancer (1977) 0.89
Cellular immune responses and prognosis in malignant lymphomas. Natl Cancer Inst Monogr (1971) 0.89
Response to BCG vaccination and survival in advanced Hodgkin's disease. Cancer (1969) 0.89
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood (1985) 0.89
Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. Ann Intern Med (1969) 0.87
Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines. J Immunol (1975) 0.86
Comparison of glucagon and epinephrine effects in the dog. Endocrinology (1966) 0.85
Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease. Cancer (1975) 0.84
Bioassay of glucagon using the isolated perfused rat liver. Endocrinology (1970) 0.84
Long survival in Hodgkin's disease. Am J Med (1970) 0.84
Demonstration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in pregnant, estrogen-treated and breast cancer-bearing rats. Oncodev Biol Med (1981) 0.84
Hepatic synthesis and secretory release of plasma alpha-2 (acute phase)-globulin appearing in malignancy. Cancer Res (1967) 0.83
Immunotherapy of chronic myelocytic leukemia. Natl Cancer Inst Monogr (1973) 0.83
Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy. J Surg Oncol (1973) 0.82
Complete remission in chronic lymphocytic leukemia and leukolymphosarcoma. Cancer (1967) 0.82
Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma. Biotechnology (N Y) (1993) 0.81
Evaluation of survival data for chronic myelocytic leukemia. Am J Hematol (1976) 0.81
Suppressive therapy of nontoxic goiter. Am J Med (1974) 0.80
Intracellular synthesis of alpha-fetoprotein and fibrinogen without secretion by Zajdela rat ascites hepatoma cells. Cancer Res (1976) 0.80
Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Cancer Res (1990) 0.80
Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. N Engl J Med (1969) 0.80
Role of the liver in the catabolism of serum haptoglobin. Proc Soc Exp Biol Med (1966) 0.79
Splenectomy for palliation of chronic myelocytic leukemia. Am J Med (1976) 0.79
Chronic granulocytic leukemia in a patient with sickle cell anemia. Am J Med (1988) 0.79
Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride. Cancer Res (1983) 0.79
The Philadelphia chromosome and Philadelphia chromosome mosaicism in chronic granulocytic leukemia. J Clin Oncol (1986) 0.78
Modulation of the physical state of cellular cholesteryl esters by 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (probucol). J Biol Chem (1992) 0.78
Immunologic deficiency in Hodgkin's disease. Tumori (1974) 0.78
Prognosis in chronic myeloid leukaemia: biology of the disease vs. treatment. Baillieres Clin Haematol (1987) 0.78
Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitro. Invest New Drugs (1991) 0.78
Pregnancy-associated alpha 2 glycoprotein (alpha 2 PAG) synthesis by human breast cancer tissue and cultured cell lines. Int J Cancer (1983) 0.77
Ferritin synthesis by splenic tumor tissue of Hodgkin's disease. Experientia (1975) 0.77
Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules. Ann N Y Acad Sci (1976) 0.77
Failure of diazoxide to affect carbohydrate metabolism of the isolated liver. Diabetes (1968) 0.77
In vitro leukocyte thymidine uptake in chronic lymphocytic leukemia. Cancer Res (1974) 0.77
Ectopic secretion of chorionic gonadotropin by a lung carcinoma. Pituitary gonadotropin and subunit secretion and prolonged chemotherapeutic remission. Am J Med (1978) 0.77
Biosynthesis of alpha fetoprotein by MCF-7 human breast cancer cells. Int J Cancer (1985) 0.77
Prognostic features at diagnosis of chronic myelocytic leukemia. Cancer (1981) 0.77
Removal of abnormal clone of leukaemic cells by splenectomy. Br Med J (1975) 0.77
Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma: a progress report. Cancer (1980) 0.77
Synthes of alpha-2 (acute phase) globulin by fetal and neonatal rat liver in vitro. Proc Soc Exp Biol Med (1969) 0.77
Relationship of serum total IgE and cell-mediated immunity in patients with Hodgkin's disease. Int Arch Allergy Appl Immunol (1977) 0.76
Effect of high spinal cord section on epinephrine hyperglycemia. Am J Physiol (1968) 0.76
The colony-forming cell in the normal and leukemia human host: responses to streptovaricin and rifamycin SV. J Natl Cancer Inst (1974) 0.76
[Contributions to recuperation in psychomotor retardation in children in early childhood in a closed community]. Pediatria (Bucur) (1969) 0.75
Significance of Ph1-negative marrow cells in Ph1-positive chronic granulocytic leukemia. Blood (1980) 0.75
Survival in Ph1-positive chronic myelocytic leukemia: relationship to findings at diagnosis and to disease kinetics after the first course of treatment. Leuk Res (1985) 0.75
Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation. Cancer Drug Deliv (1986) 0.75
Hepatic glycogenolysis induced by glucagon in a patient with type I liver glycogen disease. Biochem Med (1970) 0.75
Circulating colony-forming cells in different stages of chronic myelocytic leukemia. Cancer Res (1979) 0.75
Thymic irradiation and chronic myelogenous leukemia. N Y State J Med (1977) 0.75
[Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. Onkologie (1990) 0.75
Use of vinblastine in the terminal phase of chronic myelocytic leukemia. Cancer Treat Rep (1979) 0.75
Computer aided nystagmus analysis. Comput Programs Biomed (1975) 0.75
Decreased stainable marrow iron in chronic granulocytic leukemia. Am J Med (1986) 0.75
Progress report on immunotherapy of chronic myeloid leukemia. Boll Ist Sieroter Milan (1978) 0.75
Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia. Cancer (1987) 0.75
[Considerations on a case of Apert's syndrome]. Pediatria (Bucur) (1967) 0.75
[Studies of specific measles prevention]. Stud Cercet Inframicrobiol (1970) 0.75
Current concepts in the treatment of chronic myelocytic leukemia. Annu Rev Med (1973) 0.75
The serological detection of leukemia-associated antigens in chronic leukemia: correlation with disease status. Am J Hematol (1977) 0.75
Spontaneous remission of leukemic lymphoproliferative disease. Cancer (1971) 0.75
In vitro thymidine uptake by circulating leukocytes. J Lab Clin Med (1974) 0.75
Immunotherapy for chronic granulocytic leukaemia. Clin Haematol (1977) 0.75
In vitro leukocyte thymidine uptake and prognosis in chronic lymphocytic leukemia. Am J Med (1979) 0.75
Prognostic value of serial measurements of leukocyte thymidine uptake in well-controlled chronic myelocytic leukemia. Leuk Res (1981) 0.75
Leukocyte (3H) thymidine uptake in short-term whole-blood cultures of human and canine renal allograft recipients. J Surg Res (1973) 0.75
Thymidine uptake by circulating leukocytes in chronic myelocytic leukemia before and after therapeutic splenectomy. Leuk Res (1980) 0.75
Immunotherapy with cultured human cells and BCG. Transplant Proc (1975) 0.75